Maurizio D’Incalci

Researcher Next ID · RN-035072

Researcher · Biochemistry, Genetics and Molecular Biology

Rozzano, Italy

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Sarcoma Diagnosis and Treatment

Ovarian cancer diagnosis and treatment

Cancer therapeutics and mechanisms

Cancer Genomics and Diagnostics

RNA modifications and cancer

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.11.013
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Nature · 2017 · https://doi.org/10.1038/nature24673
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
The Lancet Oncology · 2007 · https://doi.org/10.1016/s1470-2045(07)70175-4
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
Experimental Neurology · 2007 · https://doi.org/10.1016/j.expneurol.2006.11.010
Anti-inflammatory Properties of the Novel Antitumor Agent Yondelis (Trabectedin): Inhibition of Macrophage Differentiation and Cytokine Production
Cancer Research · 2005 · https://doi.org/10.1158/0008-5472.can-04-4037

No projects listed.